The AltHost Consortium is based within the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology. Created to promote efficient, fast, and predictable manufacturing of high-quality recombinant protein drugs and vaccines, the Consortium intends to realize next-generation agile solutions for biologic manufacturing. The Consortium comprises CSIR, Merck, Novonesis, Sanofi, Sartorius, Serum Institute of India, Sunflower Therapeutics, TurtleTree, 21st.BIO, and the Bill & Melinda Gates Foundation. Through the leadership of Prof. J. Christopher Love, they work together to further experimentation, reduce research and development costs, flexibly address industry needs, improve product quality, and grow volumetric productivity of high-quality drugs and vaccines.
Company Details
- Founded
- -
- Address
- Cambridge, Massachusetts 02142, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://althost.mit.edu/
- Keywords
- biopharmaceutical manufacturing, vaccine development, R&D, strain engineering, synthetic biology, biomanufacturing, continuous fermentation, microbial hosts.
- HQ
- Cambridge, Massachusetts
Althost Consortium Questions
Althost Consortium's website is http://althost.mit.edu/
Althost Consortium's LinkedIn profile is https://www.linkedin.com/company/althost-consortium
Althost Consortium's industry is
Biotechnology Research
Althost Consortium's top competitors are
Baxerna,
Precivax Therapeutics,
Syntiron,
Abvacc,
Delonix Bioworks,
Hafion, Inc.,
Vaxeng,
Id-Antigens,
Bactivax Itn,
Renewvax Ltd.
Althost Consortium's categories are Biotechnology Research
Althost Consortium's founding year is 2018
